TMS Device NeuroStar Cleared for Obsessive-Compulsive Disorder
NeuroStar Advanced Therapy is a transcranial magnetic stimulation system that uses magnetic fields to induce neural activity in the cerebral cortex.
NeuroStar Advanced Therapy is a transcranial magnetic stimulation system that uses magnetic fields to induce neural activity in the cerebral cortex.
Both studies showed treatment with zilucoplan and rozanolixizumab demonstrated statistically significant improvements in gMG-specific outcomes.
The source of the chemicals is from the silicone tubing used as a part of the hydraulics in the machine and the dialysate lines.
The FDA extended the action date to review additional information regarding bone mineral density.
The table provided is a review of notable updates that occurred in April 2022 for investigational products in development.
Manufacturers can now adequately supply the market with varenicline at or below the acceptable intake limit of 37ng per day.
The phase 3 ADVANCE trial evaluated the efficacy and safety of efgartigimod in 131 adults with primary ITP.
The phase 3 CHAMPION-NMOSD trial evaluated ravulizumab-cwvz, a C5 complement inhibitor, in 58 adults with AQP4 Ab+ NMOSD.
The Lumipulse G β-Amyloid Ratio (1-42/1-40) test is intended to be used as an aid in adults 55 years of age and older presenting with cognitive impairment who are being evaluated for Alzheimer disease and other causes of cognitive decline.
The FDA has expressed serious concerns related to the potential health effects for patients who have consumed delta-8 THC products.